Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective

European Journal of Surgical Oncology

Volumn 41, Issue 6, 2015, Pages 758-765

  Lang, B H H ^a   Wong, C Kh ^a   Ty Chan, C ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Cancer incidence; Cost effectiveness; Economic burden; Thyroid cancer; Thyroidectomy

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; COLON CANCER; COLORECTAL CANCER; DIFFERENTIATED THYROID CANCER; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMATOMA; HUMAN; HYPOPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; VOCAL CORD PARALYSIS; WOUND INFECTION; AGED; ECONOMICS; HEALTH SERVICE; HONG KONG; INCIDENCE; PATHOLOGY; REGISTER; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; THYROID NEOPLASMS; THYROIDECTOMY; UTILIZATION;

ADULT; AGED; DIRECT SERVICE COSTS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HONG KONG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SEX FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84929134498     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.01.019     Document Type: Article

References (25)

1. B.A. Kilfoy, T. Zheng, and T.R. Holford International patterns and trends in thyroid cancer incidence, 1973-2002 Cancer Causes Control 20 2009 525 531
2. SEER cancer statistics review, 1975-2010: National Cancer Institute Surveillance Epidemiology and End Results [online]. http://seer.cancer.gov/csr/1975-2010/ [accessed 15.08.13].
3. J.R. Burgess Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997) Thyroid 12 2002 141 149
4. L. Davies, and H.G. Welch Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295 2006 2164 2167
5. Cancer incidence and mortality in Hong Kong 1983-2011. Hong Kong Cancer Registry, Hong Kong. Available: http://www3.ha.org.hk/cancereg/ [accessed 05.05.14].
6. L.G. Morris, A.G. Sikora, T.D. Tosteson, and L. Davies The increasing incidence of thyroid cancer: the influence of access to care Thyroid 23 7 2013 885 891
7. O. Husson, H.R. Haak, and L.N. van Steenbergen Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989 Endocr Relat Cancer 20 2 2013 263 271
8. R.L. Brown, J.A. de Souza, and E.E. Cohen Thyroid cancer: burden of illness and management of disease J Cancer 2 2011 193 199
9. J.L. Warren, K.R. Yabroff, A. Meekins, M. Topor, E.B. Lamont, and M.L. Brown Evaluation of trends in the cost of initial cancer treatment J Natl Cancer Inst 100 12 2008 888 897 10.1093/jnci/djn175
10. B.H. Lang, and C.K. Wong A cost-minimization analysis comparing total thyroidectomy alone and total thyroidectomy with prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma Ann Surg Oncol 21 2 2014 416 425
11. B. Aschebrook-Kilfoy, R.B. Schechter, and Y.C. Shih The clinical and economic burden of a sustained increase in thyroid cancer incidence Cancer Epidemiol Biomarkers Prev 22 7 2013 1252 1259
12. M.M. Boltz, C.S. Hollenbeak, E. Schaefer, D. Goldenberg, and B.D. Saunders Attributable costs of differentiated thyroid cancer in the elderly Medicare population Surgery 154 6 2013 1363 1369 10.1016/j.surg.2013.06.042 [discussion 1369-70]
13. A. Berger, J. Edelsberg, K. Chung, K. Ngyuyen, D. Stepan, and G. Oster Healthcare (HC) utilization and costs in patients (pts) with newly diagnosed metastatic thyroid cancer (mTC) J Clin Oncol 25 18S 2007 170 182
14. C.C. Lubitz, C.Y. Kong, and P.M. McMahon Annual financial impact of well-differentiated thyroid cancer care in the United States Cancer 120 9 2014 1345 1352
15. D.B. Preen, C.D. Holman, D.M. Lawrence, N.J. Baynham, and J.B. Semmens Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database J Clin Epidemiol 57 12 2004 1295 1304
16. S. Bernatsky, T. Linehan, and J.G. Hanly The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases J Rheumatol 38 8 2011 1612 1616 10.3899/jrheum.101149
17. M.E. Vlasschaert, S.A. Bejaimal, and D.G. Hackam Validity of administrative database coding for kidney disease: a systematic review Am J Kidney Dis 57 1 2011 29 43
18. B.H. Lang, K.P. Wong, C.Y. Cheung, K.Y. Wan, and C.Y. Lo Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis Ann Surg Oncol 20 4 2013 1329 1335
19. D.S. Cooper, G.M. Doherty, and B.R. Hauger Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
20. Hospital Authority Revisions to list of charges: G.N. 1488 to Gazette No. 12/2013 2013 Hong Kong Government Printers Available: http://www.gld.gov.hk/egazette/pdf/20131712/egn201317121488.pdf [accessed 25.08.14]
21. Pharmacy Management System/Express Dispensing System SFI drug price enquiry 2012 [accessed 15.03.14]
22. Census and Statistics Department. HKSAR, Hong Kong population projections. 2012-2041. Available: http://www.censtatd.gov.hk [accessed 18.05.14].
23. B.H. Lang, S.M. Chow, C.Y. Lo, S.C. Law, and K.Y. Lam Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers Ann Surg 246 1 2007 114 121
24. Department of Health of Hong Kong Government. 2009. Available: http://www.dh.gov.hk/english/statistics/statistics-hs/files/Health-Statistics-pamphlet-E.pdf [accessed 18.05.14].
25. M.S. Brose, C.M. Nutting, and B. Jarzab Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial Lancet 384 9940 2014 319 328 10.1016/S0140-6736(14)60421-9